Narendra Agrawal

572 total citations
70 papers, 289 citations indexed

About

Narendra Agrawal is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Narendra Agrawal has authored 70 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 28 papers in Oncology and 18 papers in Genetics. Recurrent topics in Narendra Agrawal's work include Chronic Lymphocytic Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Narendra Agrawal is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Narendra Agrawal collaborates with scholars based in India, United States and Czechia. Narendra Agrawal's co-authors include Dinesh Bhurani, Rayaz Ahmed, Sanjeev Sharma, Mukul Aggarwal, Manoranjan Mahapatra, Tulika Seth, Anurag Mehta, Priyanka Verma, Anshul Gupta and Anjan Mukherjee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Oncology.

In The Last Decade

Narendra Agrawal

47 papers receiving 279 citations

Peers

Narendra Agrawal
L. S. Zubarovskaya Russia
Young Bae Choi South Korea
Mukul Aggarwal India
Giulio Trapè Italy
Ulrik Malthe Overgaard Denmark
Giuseppina Loglisci Italy
Yasutaka Aoyama Japan
Sandra Malak France
Valkal Bhatt United States
Kazuo Hatanaka Japan
L. S. Zubarovskaya Russia
Narendra Agrawal
Citations per year, relative to Narendra Agrawal Narendra Agrawal (= 1×) peers L. S. Zubarovskaya

Countries citing papers authored by Narendra Agrawal

Since Specialization
Citations

This map shows the geographic impact of Narendra Agrawal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narendra Agrawal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narendra Agrawal more than expected).

Fields of papers citing papers by Narendra Agrawal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narendra Agrawal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narendra Agrawal. The network helps show where Narendra Agrawal may publish in the future.

Co-authorship network of co-authors of Narendra Agrawal

This figure shows the co-authorship network connecting the top 25 collaborators of Narendra Agrawal. A scholar is included among the top collaborators of Narendra Agrawal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narendra Agrawal. Narendra Agrawal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Singh, Aakanksha, et al.. (2024). A tertiary care centre experience with Elranatamab: A report of three cases. Leukemia Research Reports. 21. 100466–100466.
3.
Singh, Reema, et al.. (2024). Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience. Clinical Lymphoma Myeloma & Leukemia. 25(2). e110–e119.
4.
5.
Agrawal, Narendra, et al.. (2024). Response Adapted Dasatinib De-Escalation Strategy Compared to Upfront Low-Dose Dasatinib: A Prospective Cohort Study. Blood. 144(Supplement 1). 3154–3154. 1 indexed citations
6.
Nair, Reena, Narendra Agrawal, Manju Sengar, et al.. (2023). Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era. Frontiers in Oncology. 13. 1248723–1248723.
7.
Singh, Aakanksha, et al.. (2023). Risk and Response Adapted Approach for Treatment of Myeloma: Pushing Autologous Transplant Down the Hierarchy. Blood. 142(Supplement 1). 3600–3600.
8.
Singh, Aakanksha, et al.. (2022). Immunosuppression Boost With Mycophenolate Mofetil for Mixed Chimerism in Thalassemia Transplants. Transplantation and Cellular Therapy. 29(2). 122.e1–122.e6.
9.
Ahmed, Rayaz, et al.. (2022). Attenuated Dose Dasatinib in Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase Patients in India.. Clinical Lymphoma Myeloma & Leukemia. 23(2). e71–e77. 1 indexed citations
10.
Agrawal, Narendra, et al.. (2021). Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India. Indian Journal of Hematology and Blood Transfusion. 38(2). 264–273. 1 indexed citations
11.
12.
Agrawal, Narendra, et al.. (2021). High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol. Indian Journal of Hematology and Blood Transfusion. 38(2). 394–402. 2 indexed citations
13.
Agrawal, Narendra, et al.. (2019). Anaplastic Diffuse Large B Cell Lymphoma: A Single Center Experience. Indian Journal of Hematology and Blood Transfusion. 35(3). 557–560.
14.
Aggarwal, Mukul, et al.. (2019). Primary Plasma Cell Leukemia: A Retrospective Study of a Rare Disease From Tertiary Cancer Centre From India. Indian Journal of Hematology and Blood Transfusion. 35(4). 649–654. 3 indexed citations
15.
Agrawal, Narendra, et al.. (2017). Outcome of BCR-ABL/Philadelphia Positive Acute Lymphoblastic Leukemia: A Single Centre Experience from Developing Country. Blood. 130. 5006–5006. 2 indexed citations
16.
Sharma, Sanjeev, Suman Kumar, Narendra Agrawal, et al.. (2013). Cytomegalovirus reactivation following hematopoietic stem cell transplantation. The Journal of Infection in Developing Countries. 7(12). 1003–1007. 10 indexed citations
17.
Sharma, Sanjeev, Suman Kumar, Tulika Seth, et al.. (2012). CLINICAL PROFILE OF PATIENTS WITH RARE INHERITED COAGULATION DISORDERS: A RETROSPECTIVE ANALYSIS OF 67 PATIENTS FROM NORTHERN INDIA. SHILAP Revista de lepidopterología. 3 indexed citations
18.
Sharma, Sanjeev, Suman Kumar, Tulika Seth, et al.. (2012). CLINICAL PROFILE OF PATIENTS WITH RARE INHERITED COAGULATION DISORDERS: A RETROSPECTIVE ANALYSIS OF 67 PATIENTS FROM NORTHERN INDIA. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012057–e2012057. 18 indexed citations
19.
Sharma, Sanjeev, Sonal Jain, Pravas Mishra, et al.. (2012). An unusual clonal cytogenetic abnormality with t(15;17)(p11;q21) in a patient with severe aplastic anemia. Indian journal of human genetics. 18(2). 268–268.
20.
Cohen, Morris A., Narendra Agrawal, & Vipul Agrawal. (2006). Ganar en el mercado postventa. Harvard business review. 84(147). 104–115. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. S. Zubarovskaya Breakdown of academic impact, for papers by Young Bae Choi Breakdown of academic impact, for papers by Mukul Aggarwal Breakdown of academic impact, for papers by Giulio Trapè Breakdown of academic impact, for papers by Ulrik Malthe Overgaard Breakdown of academic impact, for papers by Giuseppina Loglisci Breakdown of academic impact, for papers by Yasutaka Aoyama Breakdown of academic impact, for papers by Sandra Malak Breakdown of academic impact, for papers by Valkal Bhatt Breakdown of academic impact, for papers by Kazuo Hatanaka
Rankless by CCL
2026